Source item
Open original source ↗Financial analysts in the health care space do not seem to understand how innovation will transform their sector. Indeed, many investors are shorting the innovators that will end chronic diseases and disrupt the traditional pharma and biotech space. Truth will win out.
Quoted context
These are the quoted author’s words.
@CRISPRTX @VertexPharma 7/I’m fully aware that many - including myself, were expecting much better financial results from $CRSP & $VRTX launch of CASGEVY. Nevertheless, here is HHS secretary @RobertKennedyJr’s recent statement regarding his unequivocal support in CRISPR & Gene Editing therapies in which he specifically mentioned CASGEVY. In my opinion this is super important and positive for the future of both CASGEVY and the Gene Editing field in general.
yaireinhorn ↗